Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Application of Real-World Data to External Control Groups in Oncology Clinical Trial Drug Development
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-01-06
DOI
10.3389/fonc.2021.695936
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real‐world evidence to support regulatory decision‐making for medicines: Considerations for external control arms
- (2020) Mehmet Burcu et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Use of real‐world data to emulate a clinical trial and support regulatory decision‐making: assessing the impact of temporality, comparator choice and methods of adjustment
- (2020) Devin Abrahami et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Single-arm trials with historical controls
- (2020) Samy Suissa EPIDEMIOLOGY
- Use of Real-World Evidence to Support FDA Approval of Oncology Drugs
- (2020) Bruce A. Feinberg et al. VALUE IN HEALTH
- Evaluating the Use of Nonrandomized Real World Data Analyses for Regulatory Decision Making
- (2019) Jessica M. Franklin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Real‐World Data for Regulatory Decision Making: Challenges and Possible Solutions for Europe
- (2019) Alison Cave et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Evolving Uses of “Real-World” Data
- (2019) Ethan Basch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Design and Evaluation of an External Control Arm Using Prior Clinical Trials and Real-World Data
- (2019) Steffen Ventz et al. CLINICAL CANCER RESEARCH
- Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials
- (2019) Gillis Carrigan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride
- (2019) Elisabetta Patorno et al. DIABETES CARE
- Nonrandomized real‐world evidence to support regulatory decision‐making: Process for a randomized trial replication project
- (2019) Jessica M. Franklin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Examining the Use of Real‐World Evidence in the Regulatory Process
- (2019) Brett K. Beaulieu‐Jones et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
- (2019) Huseyin Naci et al. BMJ-British Medical Journal
- When Context Is Hard to Come By: External Comparators and How to Use Them
- (2019) Christina Mack et al. Therapeutic Innovation & Regulatory Science
- Beyond Randomized Clinical Trials: Use of External Controls
- (2019) Heinz Schmidli et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The use of real-world data in cancer drug development
- (2018) E. Skovlund et al. EUROPEAN JOURNAL OF CANCER
- Minimizing Patient Burden Through the Use of Historical Subject-Level Data in Innovative Confirmatory Clinical Trials
- (2018) Jessica Lim et al. Therapeutic Innovation & Regulatory Science
- Comparative effectiveness from a single-arm trial and real-world data: alectinib versus ceritinib
- (2018) Jessica Davies et al. Journal of Comparative Effectiveness Research
- Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
- (2018) Lawrence Blonde et al. ADVANCES IN THERAPY
- Accelerating anticancer drug development — opportunities and trade-offs
- (2018) Sharyl J. Nass et al. Nature Reviews Clinical Oncology
- Methodological challenges for the evaluation of clinical effectiveness in the context of accelerated regulatory approval: an overview
- (2017) Nerys Woolacott et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Real-world Data for Clinical Evidence Generation in Oncology
- (2017) Sean Khozin et al. JNCI-Journal of the National Cancer Institute
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-world Data for Clinical Evidence Generation in Oncology
- (2017) Sean Khozin et al. JNCI-Journal of the National Cancer Institute
- Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients WithALK-Rearranged Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2
- (2016) Lucio Crinò et al. JOURNAL OF CLINICAL ONCOLOGY
- Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia
- (2016) N Gökbuget et al. Blood Cancer Journal
- The role of nonrandomized trials in the evaluation of oncology drugs
- (2015) R Simon et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer
- (2013) Melanie Poulin-Costello et al. Targeted Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started